GEHC GE HEALTHCARE TECHNOLOGIES I revenue, earnings and financials

For the quarter ended June 30, 2026, GE HEALTHCARE TECHNOLOGIES I reported revenue of $5.30B (up 5.8% from a year earlier), net income of $561M and diluted EPS of $1.24; over the last four quarters revenue was $21.3B and net income $1.98B; for the fiscal year ended December 2025 revenue was $20.6B, up 4.8% on the year before.

GEHC annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $20.6B, gross profit $8.25B, operating income $2.76B, net income $2.08B (margin 10.1%), EPS $4.55
• Fiscal year ended Dec 2024: revenue $19.7B, gross profit $8.21B, operating income $2.63B, net income $1.99B (margin 10.1%), EPS $4.34
• Fiscal year ended Dec 2023: revenue $19.6B, gross profit $7.92B, operating income $2.44B, net income $1.57B (margin 8.0%), EPS $3.03
• Fiscal year ended Dec 2022: revenue $18.3B, gross profit $7.18B, operating income $2.52B, net income $1.92B (margin 10.4%), EPS $4.22
• Fiscal year ended Dec 2021: revenue $17.6B, gross profit $7.17B, operating income $2.80B, net income $2.25B (margin 12.8%), EPS $4.95

GEHC quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $5.30B (up 5.8% year over year), net income $561M, EPS $1.24
• Quarter ended Mar 31, 2026: revenue $5.13B (up 7.4% year over year), net income $389M, EPS $0.85
• Quarter ended Dec 31, 2025 (from the annual report): revenue $5.70B (up 7.1% year over year), net income $588M, EPS $1.28
• Quarter ended Sep 30, 2025: revenue $5.14B (up 5.8% year over year), net income $446M, EPS $0.98
• Quarter ended Jun 30, 2025: revenue $5.01B (up 3.5% year over year), net income $486M, EPS $1.06
• Quarter ended Mar 31, 2025: revenue $4.78B (up 2.7% year over year), net income $564M, EPS $1.23
• Quarter ended Dec 31, 2024 (from the annual report): revenue $5.32B (up 2.2% year over year), net income $721M, EPS $1.58
• Quarter ended Sep 30, 2024: revenue $4.86B (up 0.9% year over year), net income $470M, EPS $1.02
• Quarter ended Jun 30, 2024: revenue $4.84B (up 0.5% year over year), net income $428M, EPS $0.93
• Quarter ended Mar 31, 2024: revenue $4.65B (down 1.2% year over year), net income $374M, EPS $0.81
• Quarter ended Dec 31, 2023 (from the annual report): revenue $5.21B (up 5.4% year over year), net income $403M, EPS $0.89
• Quarter ended Sep 30, 2023: revenue $4.82B (up 5.4% year over year), net income $375M, EPS $0.82
• Quarter ended Jun 30, 2023: revenue $4.82B (up 7.4% year over year), net income $418M, EPS $0.91
• Quarter ended Mar 31, 2023: revenue $4.71B (up 8.4% year over year), net income $372M, EPS $0.41
• Quarter ended Dec 31, 2022 (from the annual report): revenue $4.94B, net income $555M, EPS $1.22
• Quarter ended Sep 30, 2022: revenue $4.58B, net income $487M, EPS $1.07
• Quarter ended Jun 30, 2022: revenue $4.48B, net income $485M, EPS $1.07
• Quarter ended Mar 31, 2022: revenue $4.34B, net income $389M, EPS $0.86

GEHC cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow n/a, share buybacks $200M, dividends $0.14 per share
• Fiscal year ended Dec 2024: operating cash flow n/a, share buybacks $0, dividends $0.13 per share
• Fiscal year ended Dec 2023: operating cash flow n/a, share buybacks $0, dividends $0.12 per share

GEHC balance sheet

• Jun 30, 2026: cash $2.08B, total assets $37.2B, total liabilities $26.0B, shareholders' equity $11.0B, long-term debt $10.1B
• Mar 31, 2026: cash $2.26B, total assets $37.1B, total liabilities $26.2B, shareholders' equity $10.7B, long-term debt $10.1B
• Dec 31, 2025: cash $4.49B, total assets $36.9B, total liabilities $26.3B, shareholders' equity $10.4B, long-term debt $9.50B
• Sep 30, 2025: cash $4.01B, total assets $36.1B, total liabilities $25.9B, shareholders' equity $9.99B, long-term debt $8.28B
• Jun 30, 2025: cash $3.74B, total assets $35.5B, total liabilities $25.5B, shareholders' equity $9.71B, long-term debt $8.27B
• Mar 31, 2025: cash $2.45B, total assets $33.6B, total liabilities $24.2B, shareholders' equity $9.19B, long-term debt $6.76B
• Dec 31, 2024: cash $2.87B, total assets $33.1B, total liabilities $24.4B, shareholders' equity $8.45B, long-term debt $7.45B
• Sep 30, 2024: cash $3.55B, total assets $33.9B, total liabilities $25.3B, shareholders' equity $8.32B, long-term debt $9.31B

What is GEHC's revenue?

GE HEALTHCARE TECHNOLOGIES I reported $21.3B of revenue over its last four quarters, through June 30, 2026.

Is GEHC profitable?

Yes. GE HEALTHCARE TECHNOLOGIES I earned $1.98B over the last four quarters.

What is GEHC's EPS?

Diluted earnings per share over the last four quarters were $4.35; $1.24 in the latest quarter.

Does GEHC pay a dividend?

GE HEALTHCARE TECHNOLOGIES I paid $0.14 per share in dividends in the fiscal year ended December 2025.

GEHC ownership and insider trades · All stocks